On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Earth is 70% ocean and 70% ocean bottom!
- How can we access the deep ocean systems?
- Deep ocean sediment sampling
- Unknown actinomycete bacteria cultivated
- New phylogenetic diversity: marine actinomycetes
- Bioactive marine microbial metabolites
- Problems with marine microbial drug discovery
- Three species of Salinispora recognized
- Chemical study - Salinispora tropica CNB-440
- Salinosporamide A, a potent anticancer agent
- Sal A proteasome enzymatic specificity
- Sal A reactivity during binding to 20S proteasome
- Ammosamides A and B - Mar 14 group
- Ammosamides A and B
- Ammosamides A and B cancer bioactivities
- Cell cycle response to ammosamide B
- Protein target of ammosamide B
- Protein target of ammosamide B is myosin II
- X-ray structure of myosin II
- Predicted myosin II binding site (docking studies)
- The MAR 4 actinomycetes - Streptomycetaceae
- The MAR 4 actinomycetes metabolites
- Napyradiomycins induce rapid cytotoxicity
- Napyradiomycins and apoptosis in HCT-116 cells
- Preparation of fluorescent coumarin derivatives
- Two MAR 4 probes bind to the ER in HeLa cells
- Immunoprecipitation leads to “Grp94” as target
- Role of the Hsp90 proteins in cell regulation
- Streptomyces strain CNH-287, a new species
- X-ray structure of chlorizidine A
- Reactivity of chlorizidine A
- Synthesis of the chlorizidine A fluorescent probe
- Incubation of chlorizidine A probe & HCT-116 cells
- Immunoprecipitation leads to ID of ENO1
- Crystal structure of human enolase 1
- Concluding remarks
- Acknowledgements
Topics Covered
- Structurally unprecedented marine bacterial metabolites
- Developing new molecules for the treatment of cancer
- Discovery of the protein targets of apoptosis-inducing metabolites
- Developing the potential of natural products to treat cancer by alternative mechanisms of action
- Discoveries of GRP94, myosin II and related cellular proteins as targets of new cytotoxins
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fenical, W. (2021, September 23). Deep ocean microorganisms yield mechanistically-novel anticancer agents [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/OVMW7974.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. William Fenical has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Deep ocean microorganisms yield mechanistically-novel anticancer agents
A selection of talks on Pharmaceutical Sciences
Hide